It’s Worth A Gamble To Have A Position In Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) At $8.85.
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)’s traded shares stood at 4.79 million during the last session, with the company’s beta value hitting 1.08. At the close of